Skip to search
Skip to main content
Back to Search
Start Over
Clinical Relevance of High Plasma Trough Levels of the Kinase Inhibitors Crizotinib, Alectinib, Osimertinib, Dabrafenib, and Trametinib in NSCLC Patients
Authors :
Afd Pharmacoepi & Clinical Pharmacology Pharmacoepidemiology and Clinical Pharmacology Lin, Lishi Barkman, HJ Smit, EF de Langen, AJ Steeghs, N Beijnen, JH Huitema, ADR Afd Pharmacoepi & Clinical Pharmacology Pharmacoepidemiology and Clinical Pharmacology Lin, Lishi Barkman, HJ Smit, EF de Langen, AJ Steeghs, N Beijnen, JH Huitema, ADR
Publication Year :
2024
Details
Database :
OAIster
Notes :
English
Publication Type :
Electronic Resource
Accession number :
edsoai.on1435847414
Document Type :
Electronic Resource